Top 10 questions to ask when choosing IT incident management software
Discover the most important questions to evaluate incident management platforms and make a smarter investment for your organization's resilience.
Industry analyst reports
Keep up to date on recent Everbridge news, events, and content, including from our recent thought leadership events and articles.
Report recognition
Below are reports* † in which we’ve received recognition. In addition to those published here, we are also excited to be included in:
- Gartner® Hype Cycle™ for Consumer Engagement & Experience in Healthcare and Life Sciences, July 31st 2023
- Gartner® Hype Cycle™ for Public Safety and Law Enforcement, July 25th 2023
- Gartner® Hype Cycle™ for Cyber Risk Management, July 25th 2023
- Gartner® Hype Cycle™ for Real-Time Health System Technologies, July 17th 2023
- Gartner® Hype Cycle™ for Site Reliability Engineering, July 17th 2023
- Gartner® Hype Cycle™ for I&O Automation, July 14th 2023
- Gartner® Hype Cycle™ for ITSM, July 14th 2023
- Gartner® Hype Cycle™ for Monitoring and Observability, July 10th 2023
- The Forrester Wave™: Process-Centric AI For IT Operations (AIOps), Q2 2023
- Forrester: The External Threat Intelligence Service Providers Landscape, Q1 2023
- Forrester: The Process-Centric AIOps Landscape, Q1 2023
- Forrester: The State of Threat Intelligence, Q2 2023
- Verdantix Tech Roadmap: EHS Technologies, March 2023
- Verdantix Strategic Focus: Protecting Workers from Climate Risk, February 2023
- Verdantix Tech Roadmap: Climate Risk Digital Solutions, January 2023
- Verdantix Smart Innovators: ESG Reporting and Data Management Software, January 2023
- Verdantix Green Quadrant: Integrated Smart Security Software, Q1 2023
Everbridge Suite 2025 unwrapped: Year in review
Join Customer Success for a review of 2025 Everbridge Suite enhancements, and gain expert guidance to prepare and optimize your system for success in 2026!
Building a resilience committee: Practical steps to strengthen business continuity
Casey and Shay kick off with festive banter before welcoming Brad Henske of Carilion Clinic to unpack how a Risk & Resilience Committee unites risk, ITDR, emergency/crisis communications, and BC to achieve operational resilience. He covers committee scope, mission alignment, and collaboration via curiosity, regular cross-functional touchpoints, and shared accountability. The episode distinguishes strategic resilience goals from tactical BC execution and stresses first steps: define the model, engage partners, begin the work.
Beyond duty of care: How travel risk management protects business continuity
Learn how leading organizations are leveraging Everbridge Travel Protector and 360 to safeguard both people and performance.
Coordinating a critical evacuation during conflict in the Middle East
By integrating global resources, live intelligence, and expert crisis management, Everbridge once again demonstrated its commitment to safeguarding its clients when every second counts.
You’re In Charge: Can You Keep the Business Running?
Step into a crisis as the leader everyone relies on. Make real-world decisions, see the impact, and explore how your choices shape organizational response and resilience – in this interactive scenario created in partnership with Security Magazine.
*Forrester reports are available to Forrester subscribers or for purchase.
†Gartner reports are available for Gartner subscribers only
†GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
†Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
